Beijing Centergate Technologies (Holding) Co., Ltd. (000931.SZ) Stock Price, Financials & Summary | drillr

Skip to content

Sign in Sign up

Price chart

Aug 20Aug 25Aug 28Sep 2Sep 7Sep 10Sep 15Sep 18

Key dataSep 18, 2026

OpenCNY 4.44

From 52W high−1.75%

Volume14.81M

Market capCNY 4.22B

P/E (TTM)88.1x

P/S (TTM)1.5x

Div yield0.45%

Key dataSep 18, 2026

Open

CNY 4.44

From 52W high

−1.75%

Volume

14.81M

Market cap

CNY 4.22B

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

16.8x

P/E (TTM)

88.1x

RSI (14)

46.2

MomentumView details →

1D Return

+10.02%

YTD Return

−9.03%

ValuationView details →

P/E (Fwd)

—

P/E (TTM)

88.1x

EV/EBITDA

16.8x

EV/Sales

1.9x

P/S (TTM)

1.5x

P/B (TTM)

2.6x

ProfitabilityView details →

Gross Margin

55.95%

Net Margin

0.69%

EBITDA Margin

11.25%

ROE (TTM)

0.98%

ROA (TTM)

0.40%

Asset Turnover

0.58x

GrowthView details →

Revenue YoY

−9.56%

EPS YoY

−72.54%

FCF YoY

—

Revenue CAGR 3Y

+5.84%

EPS CAGR 3Y

−0.70%

EBITDA YoY

—

MomentumView details →

1D Return

+10.02%

YTD Return

−9.03%

1Y Return

−13.81%

RSI (14)

46.2

vs 50D SMA

−0.24%

vs 200D SMA

−6.60%

Capital & dividendView details →

Debt/Equity

0.63x

Current Ratio

1.17x

Quick Ratio

1.05x

Div Yield

0.45%

Div Rate

CNY 0.02

Div Growth 1Y

−76.80%

EarningsView details →

EPS (Actual)

−CNY 0.02

EPS Surprise

—

Beats (12Q)

—

Next Q EPS Est

—

Avg Surprise (4Q)

—

Rev Surprise

—

Financials snapshotView financials →

Revenue (TTM)

2.30B

Net Income (TTM)

15.87M

Op. CF (TTM)

49.24M

Latest newsMore news →

Shandong Huasu Pharmaceutical, a subsidiary of Zhongguancun, received a drug registration certificate from China's National Medical Products Administration for its bisoprolol amlodipine tablets for hypertension treatment.7d ago

Zhongguancun announced that its controlling shareholder Gome Holdings' shares have been fully judicially frozen, with new freezes and sequential freezes added, posing risks to control stability.31d ago

Similar companies

顺博合金002996.SZ 江天化学300927.SZ 优优绿能301590.SZ ST凯利300326.SZ 冰山冷热000530.SZ 同兴达002845.SZ Find similar companies →

Latest newsMore news →

Shandong Huasu Pharmaceutical, a subsidiary of Zhongguancun, received a drug registration certificate from China's National Medical Products Administration for its bisoprolol amlodipine tablets for hypertension treatment.7d ago Zhongguancun announced that its controlling shareholder Gome Holdings' shares have been fully judicially frozen, with new freezes and sequential freezes added, posing risks to control stability.31d ago Zhongguancun's subsidiary Beijing Huasu Pharmaceutical Co., Ltd. received a drug registration certificate from the National Medical Products Administration for its oxycodone hydrochloride extended-release tablets (40mg), approved for treating severe pain.49d ago